Genetic Modulation of Brugada Syndrome by a Common Polymorphism

被引:43
作者
Lizotte, Eric [2 ,3 ]
Junttila, M. Juhani [1 ]
Dube, Marie Pierre [2 ,3 ]
Hong, Kui [4 ]
Benito, Begona [5 ]
De Zutter, Marc [6 ]
Henkens, Stefan [6 ]
Sarkozy, Andrea [6 ]
Huikuri, Heikki V. [1 ]
Towbin, Jeffrey [7 ]
Vatta, Matteo
Brugada, Pedro [2 ,3 ,8 ]
Brugada, Josep [5 ]
Brugada, Ramon [2 ,3 ]
机构
[1] Univ Oulu, Inst Clin Med, Dept Internal Med, Ctr Excellence Res, Oulu, Finland
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[3] Univ Montreal, Montreal, PQ, Canada
[4] Nanchang Univ, Nanchang, Peoples R China
[5] Hosp Clin Barcelona, Thorax Inst, Dept Cardiol, Barcelona, Spain
[6] UZ Brussel VUB, Heart Rhythm Management Inst, Brussels, Belgium
[7] Cincinnati Childrens Hosp, Cincinnati, OH USA
[8] Baylor Coll Med, Houston, TX 77030 USA
关键词
sudden death; arrhythmia; genetics; electrocardiography; ion channels; CARDIAC CONDUCTION; SCN5A MUTATION; FIBRILLATION; CHINESE; DEATH; QT;
D O I
10.1111/j.1540-8167.2009.01508.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic Modulation of Brugada Syndrome by a Common Polymorphism. Background: Brugada syndrome predisposes some subjects to ventricular tachyarrhythmias and sudden cardiac death. Mutations in SCN5A gene have been associated with similar to 25% of Brugada syndrome patients. A common variant in SCN5A, H558R has shown to improve sodium channel activity in mutated channels. We studied whether common variant H558R has any clinical implications in the phenotype of Brugada syndrome. Methods: Our study population consisted of Brugada syndrome subjects 75 with SCN5A mutation and 92 without SCN5A mutation. Their mean age was 39 +/-15 and 42 +/-17 years, and 65% and 86% were male, respectively. We measured PR-, QRS-, QTc-intervals from leads II and V2 of the 12-lead ECG. We also evaluated J-point amplitude from lead V2 and R'/S ratio from lead aVR (the "aVR sign"). The H558R (A -> G) genotype was detected with direct sequencing of the SCN5A gene. Results: The AA genotype carriers had longer QRS duration in lead II (P = 0.017) and higher J-point elevation in lead V2 (P = 0.013), higher "aVR sign" (P = 0.005) and a trend toward more subjects with symptoms (P = 0.067) than G allele carriers. None of the results were significant in Brugada syndrome subjects without SCN5A mutation. Conclusion: The common variant H558R seems to be a genetic modulator of Brugada syndrome among carriers of a SCN5A mutation, in whom the presence of the less common allele G improves the ECG characteristics and clinical phenotype. (J Cardiovasc Electrophysiol, Vol. 20, pp. 1137-1141, October 2009)
引用
收藏
页码:1137 / 1141
页数:5
相关论文
共 50 条
  • [31] An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing
    Kapplinger, Jamie D.
    Tester, David J.
    Alders, Marielle
    Benito, Begona
    Berthet, Myriam
    Brugada, Josep
    Brugada, Pedro
    Fressart, Veronique
    Guerchicoff, Alejandra
    Harris-Kerr, Carole
    Kamakura, Shiro
    Kyndt, Florence
    Koopmann, Tamara T.
    Miyamoto, Yoshihiro
    Pfeiffer, Ryan
    Pollevick, Guido D.
    Probst, Vincent
    Zumhagen, Sven
    Vatta, Matteo
    Towbin, Jeffrey A.
    Shimizu, Wataru
    Schulze-Bahr, Eric
    Antzelevitch, Charles
    Salisbury, Benjamin A.
    Guicheney, Pascale
    Wilde, Arthur A. M.
    Brugada, Ramon
    Schott, Jean-Jacques
    Ackerman, Michael J.
    HEART RHYTHM, 2010, 7 (01) : 33 - 46
  • [32] Brugada syndrome
    Bernard, M
    Marie, I
    Durand, A
    Héron, F
    Lévesque, H
    REVUE DE MEDECINE INTERNE, 2005, 26 (07): : 592 - 593
  • [33] Brugada syndrome
    Bastiaenen, Rachel
    Behr, Elijah R.
    CARDIOGENETICS, 2011, 1 : 8 - 13
  • [34] Brugada Syndrome
    Mizusawa, Yuka
    Wilde, Arthur A. M.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (03) : 606 - 616
  • [35] Natural history of Brugada syndrome - Insights for risk stratification and management
    Priori, SG
    Napolitano, C
    Gasparini, M
    Pappone, C
    Della Bella, P
    Giordano, U
    Bloise, R
    Giustetto, C
    De Nardis, R
    Grillo, M
    Ronchetti, E
    Faggiano, G
    Nastoli, J
    CIRCULATION, 2002, 105 (11) : 1342 - 1347
  • [36] The brugada syndrome
    Brugada P.
    Brugada R.
    Brugada J.
    Current Cardiology Reports, 2000, 2 (6) : 507 - 514
  • [37] Brugada syndrome
    Jellins, Jessica
    Milanovic, Mitchell
    Taitz, David-Joel
    Wan, S. H.
    Yam, P. W.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (02) : 159 - 167
  • [38] The Brugada Syndrome
    Pedro Brugada
    Josep Brugada
    Ramon Brugada
    Cardiovascular Drugs and Therapy, 2001, 15 : 15 - 17
  • [39] Putative role of Brugada syndrome genes in familial atrial fibrillation
    Maltese, P. E.
    Aldanova, E.
    Kriuchkova, N.
    Averianov, A.
    Manara, E.
    Paolacci, S.
    Bruson, A.
    Miotto, R.
    Sartori, M.
    Guerri, G.
    Zuntini, M.
    Marceddu, G.
    Tezzele, S.
    Tadtaeva, K.
    Chernova, A.
    Aksyutina, N.
    Nikulina, S.
    Nodar, S.
    Bertelli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (17) : 7582 - 7598
  • [40] Brugada syndrome
    Wolpert C.
    Herrera-Siklody C.
    Parade U.
    Strotmann C.
    Rüb N.
    Herzschrittmachertherapie + Elektrophysiologie, 2013, 24 (4) : 209 - 216